FCGR2A and neoplasm: Targeted ADCs with wt Fc potently induced IRF3 reporter activity, which required ADC binding to both tumor antigen and FcγR, since minimal activity was observed with Fc-mutant and non-binding control ADCs (Fig. 1e).